Another candidate developed through this platform includes a dual GIP/GLP-1 gene therapy to treat obesity, currently in preclinical development
InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: InfiniWell BPC-157 500 mcg Pro Delayed Release Ingredients: Serving Size: 1 Capsule Body Protective Compound (as BPC-157 Arginate Salt) 500 mcg Salcaprozate Sodium (SNAC) 3 mg Other Ingredients: Rice Powder, Microcrystalline Cellulose, Vegetable Capsule (Hypromellose, Gellan Gum) Delayed-Release Capsules, Gluten Free, Dairy Free, Soy Free, Non-GMO Warnings: If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.
Weight loss, even when desired, can be emotionally complex, particularly for patients whose relationship with their body has been shaped by depression, anxiety, or disordered eating patterns
Mezclada con una buena dieta y ejercicio, va genial
GLP-1RAs may provide therapeutic opportunities in conditions such as PCOS and obesity-related infertility